A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. (IRIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01785992
Recruitment Status : Completed
First Posted : February 7, 2013
Last Update Posted : March 24, 2015
Cancer Research UK
Information provided by (Responsible Party):
Imperial College London

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2014
  Study Completion Date : December 2014